Dieta Brandsma

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp et al. · The Lancet Oncology · 2014 · 753 citations

Medicine, Oncology, Pharmacotherapy +16

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Émilie Le Rhun, Michael Weller, Dieta Brandsma et al. · Annals of Oncology · 2017 · 639 citations · Full text

Medicine, Neurosurgery, Oncology +16

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

Walter Taal, Dieta Brandsma, Hein G. de Bruin et al. · Cancer · 2008 · 464 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Single-cell spatial immune landscapes of primary and metastatic brain tumours

Elham Karimi, Miranda W. Yu, Sarah M. Maritan et al. · Nature · 2023 · 392 citations · Full text

Medicine, Immunology, Oncology +17

Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance

Leila Akkari, Robert L. Bowman, Jeremy Tessier et al. · Science Translational Medicine · 2020 · 322 citations

Medicine, Immunology, Oncology +17